Detalhe da pesquisa
1.
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.
Biol Blood Marrow Transplant
; 21(6): 1074-82, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25805300
2.
Observational Safety Study of Clottafact® Fibrinogen Concentrate: Real-World Data in Mexico.
Clin Drug Investig
; 40(5): 485-491, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32215860